NICE is assessing ocrelizumab for primary progressive MS (PPMS) to decide whether it should be prescribed by the NHS in England and Wales. Scotland and Northern Ireland will carry out separate appraisals.
The MS Trust will be explaining to NICE why we think ocrelizumab should be made available on the NHS. To help us make a strong case, we want to hear your experiences of living with PPMS, your views on current NHS care for PPMS and your thoughts on ocrelizumab.
We’d like to hear from you if
- you have primary progressive MS
- you have a different type of MS, but would like to add your views
- you are a partner / friend / relative / carer of someone with PPMS
- you are a health professional providing care for people with PPMS
Tell us what you think by completing this short questionnaire by 14 February.
Covid boosters and shielding changes for people with MS
21 Sep 2021 - 00:00
From September 2021, the shielding programme for clinically extremely vulnerable people will close. A booster programme will top-up Covid vaccines for vulnerable people.
A sticky situation
13 Sep 2021 - 00:00
For some people with MS, relapses can be a big part of their condition. In this blog, Elaine discusses the unpredictability of multiple sclerosis, including what it feels like to be in a relapse.
Cycling 1,000km for the MS Trust
1 Sep 2021 - 00:00
Fundraiser, George shares his motivations for completing a 1000km cycling challenge on behalf of the MS Trust as well as some useful tips for others thinking of taking on their own physical fundraising challenge.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.